{"id":391852,"date":"2020-12-02T09:28:38","date_gmt":"2020-12-02T14:28:38","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=391852"},"modified":"2020-12-02T09:28:38","modified_gmt":"2020-12-02T14:28:38","slug":"rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/","title":{"rendered":"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Dec.  02, 2020  (GLOBE NEWSWIRE) &#8212; Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public.<\/p>\n<p align=\"justify\">On November 17, 2020, after market hours, Sonoma filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that Sonoma\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d Sonoma continued that the financial statements for this time period \u201ccontained material errors\u201d and that \u201cthe Company will need to restate them.\u201d<\/p>\n<p align=\"justify\">On this news, Sonoma\u2019s share price fell $1.10 per share, or more than 14%, over the next few trading days to close at $6.63 per share on November 20, 2020.<\/p>\n<p align=\"justify\">Rosen Law Firm is preparing a securities lawsuit on behalf of Sonoma shareholders. If you purchased securities of Sonoma please visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g21A_X3SOHfdebrhkICp9OHIeZ_75Mw-08kt7EuQ_pbLlYwhoytUfzlDSa9CCJOLEMk1KFYT9Q395sJxBvqFYpXj_DZ-L9MHWgh1179X3wZynH4lMiPi3-b4NJKiypqwPptHcKawj3mrhEYxp1waIlN51J2bmKNKfPFatLJhGgg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.rosenlegal.com\/cases-register-1992.html<\/a> to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xeLJ-lmu18WX1IZZN_xcQPgSjlNWMNRh2f4zZgoyqArUPLlvmtzcTcffKkkxlngwgxPW1ayrb-psDb3sc86B8M4oM4GitoCqCKps6ogVVkA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mailto:pkim@rosenlegal.com<\/a> or cases@rosenlegal.com.<\/p>\n<p align=\"justify\">Follow us for updates on LinkedIn: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nAwcSB_US7LF6mlA883Uuf3wkRByKLNxQog5XAcv49q8rEVlUIluISOYCdIXCUhLwy7Co449419zpSsJlo0zJIzZjoqQ2C7B-3EwbEpiptC-WLdS9ieEV7BuZlqN8d56IscNM5NTAQA4kkq5NepfXhpscQyb4t5Nlc0ZC2PNOxU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a> or on Twitter: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nAwcSB_US7LF6mlA883UuTah6X8-BwYI8f_qcDcVW_VwiALwRsh1lsS9GoiqK_uBo5gJr28po86o3JMDOuM1O0InEJihgC7pBtYek5wSL45Y-rimsyXIg8Lb_Fxs_iix\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nAwcSB_US7LF6mlA883UuZKkciD9UKA_rX6plH6pck-QpjLGls2nPdWYq0xHUoPbjV4x2qJJeUoKBjJ46hffFZd1hF-6-SMSHeSZthWyZfytYaCcSa1gNd9UmY78LF2k\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.facebook.com\/rosenlawfirm<\/a>.<\/p>\n<p align=\"justify\">Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm\u2019s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p align=\"justify\">Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p align=\"justify\">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>Contact Information:<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laurence Rosen, Esq.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Phillip Kim, Esq.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The Rosen Law Firm, P.A.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0275 Madison Avenue, 40<sup>th<\/sup> Floor<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0New York, NY 10016<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Tel: (212) 686-1060<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Toll Free: (866) 767-3653<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fax: (212) 202-3827<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nTYeknWdXLEXFGoszGJKENPqQsUU2SuTS5OTB_xW6Odj07o9vJb3wovR1-pfdfXyGBIANRoFEzcyPJiuI_GbcZ3OLFmGr2ijaeyg35GZoCY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lrosen@rosenlegal.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kA8axNjYm9z9yYzrE2Try51pU03ICfdSBgv2z-RNmm-pep3ey7VA-VYY6lGeQhGOGQ560-M50N7UlI3tDH2Qqe9AsSvqm8Befdzqy0DKuF8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">pkim@rosenlegal.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zwomGIdxPYzRjqxwCOq6xdlNGwGa68YIAa8VY3r3tEkKPMLemWJfLVs5-guKEIgqK8TQjU-oqzDcEVFZXkmr-0zfpDky_P-zAa1qD-9s3m0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cases@rosenlegal.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IvboBvIV8yr-ooYzcb3mwX5QHT42ADlGmSwgue9YFhFxta9mKRZvhviLcabdyYNlhcUqINcBlPxWxDClmQglhm3hjrMdiNWmNqmOYawHprA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.rosenlegal.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8bf57e9c-a064-4f93-9382-03dfa2797b6e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public. On November 17, 2020, after market hours, Sonoma filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that Sonoma\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d Sonoma continued that the financial statements for this time period \u201ccontained material errors\u201d and that \u201cthe Company will need to restate them.\u201d On this news, Sonoma\u2019s share price fell $1.10 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-391852","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public. On November 17, 2020, after market hours, Sonoma filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that Sonoma\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d Sonoma continued that the financial statements for this time period \u201ccontained material errors\u201d and that \u201cthe Company will need to restate them.\u201d On this news, Sonoma\u2019s share price fell $1.10 &hellip; Continue reading &quot;ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-02T14:28:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA\",\"datePublished\":\"2020-12-02T14:28:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/\"},\"wordCount\":394,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/\",\"name\":\"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=\",\"datePublished\":\"2020-12-02T14:28:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/","og_locale":"en_US","og_type":"article","og_title":"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA - Market Newsdesk","og_description":"NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) &#8212; Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public. On November 17, 2020, after market hours, Sonoma filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that Sonoma\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d Sonoma continued that the financial statements for this time period \u201ccontained material errors\u201d and that \u201cthe Company will need to restate them.\u201d On this news, Sonoma\u2019s share price fell $1.10 &hellip; Continue reading \"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-02T14:28:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA","datePublished":"2020-12-02T14:28:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/"},"wordCount":394,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/","name":"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=","datePublished":"2020-12-02T14:28:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTU3MCMzODUzMDYyIzIwMjA0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-respected-investor-counsel-continues-to-investigate-securities-claims-against-sonoma-pharmaceuticals-inc-snoa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. \u2013 SNOA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=391852"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391852\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=391852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=391852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=391852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}